WASHINGTON — Timing matters when it comes to combining immunotherapy with chemoradiation in limited-stage small cell lung cancer (SCLC), according to the phase 3...
BARCELONA, Spain — Ethnic Chinese immigrants affected by cancer are a particularly vulnerable group and may face significant barriers to receiving proper diagnosis and...
BARCELONA — Intravenous patient-controlled administration of hydromorphone offers better pain control and higher patient satisfaction compared with conventional oral morphine in managing severe cancer...
The US Food and Drug Administration (FDA) has expanded the approval of nivolumab (Opdivo, Bristol Myers Squibb) for the treatment of certain patients with...